Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis
- 31 August 1996
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 175 (2) , 396-401
- https://doi.org/10.1016/s0002-9378(96)70152-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Long-acting injectable contraception with depot medroxyprogesterone acetateAmerican Journal of Obstetrics and Gynecology, 1994
- Improving the classification of endometriosis*Human Reproduction, 1993
- A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD usersContraception, 1993
- Medical treatment of mild endometriosis in infertile women: analysis of a failureHuman Reproduction, 1990
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind studyFertility and Sterility, 1990
- Buserelin versus danazol in the treatment of endometriosis-associated infertilityAmerican Journal of Obstetrics and Gynecology, 1989
- Treatment of Endometriosis with Estrogen-Progestin Combination and Progestogens AloneClinical Obstetrics and Gynecology, 1988
- Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetateAmerican Journal of Obstetrics and Gynecology, 1988
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectivenessAmerican Journal of Obstetrics and Gynecology, 1981